SALT LAKE CITY - Co-Diagnostics, Inc. (NASDAQ:CODX) announced Monday that the Australian Patent Office has granted the company its first patent for its point-of-care PCR testing platform. The microcap ...
Roche announced the CE Mark for its cobas BV/CV (Bacterial Vaginosis/Candida Vaginitis) assay to accurately identify specific bacteria and yeast responsible for BV and CV in vaginal samples from ...
Late-night cravings aren’t the only thing DoorDash can help with. Starting this week, women can order a first-of-its-kind, at-home swab test for three common sexually transmitted infections and have ...
Scientists at the ICAR-Central Institute of Fisheries Education, Mumbai, have developed a species-specific PCR test 1 that can rapidly and accurately detect Cronobacter sakazakii, a food-borne ...
As we get into another winter holiday season, COVID is still part of our lives. And although it's hard to predict exactly what this year's cold, flu and coronavirus season will look like, experts want ...
A new biotechnology company in McKinney has ambitions to become the world’s first fully integrated platform for polymerase chain reaction (PCR) testing — the same technology behind a common COVID-19 ...
An expert panel convened by the nation’s top post-acute care medical organization has recommended against the routine use of urine PCR tests to diagnose urinary tract infections. Such tests have ...
The COVID-19 pandemic yielded important advances in testing for respiratory viruses, but it also exposed important unmet needs in screening to prevent the spread of infections in high-risk settings.
Phase 1 trial of SHR-A2102, a nectin-4–directed antibody drug conjugate (ADC), in advanced solid tumors. Prediction of survival after de-escalated neoadjuvant therapy in HER2+ early breast cancer: A ...
The FDA has cleared its first completely at-home sexual health test for women, available over-the-counter to screen for chlamydia, gonorrhea and trichomoniasis. The single-use kit from Visby Medical ...
Credit: Visby Medical. The approval was based on a clinical study that included 2203 females aged 14 years and older. The Food and Drug Administration (FDA) has cleared the Visby Medical Women’s ...
A novel at-home molecular test proved highly accurate for diagnosing three common sexually transmitted infections (STIs) in females, according to a clinical study from the test's manufacturer. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback